ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1179

A Multi-Organ Inflammatory Condition with Features of Idiopathic Multicentric Castleman’s Disease and IgG4-Related Disease: An Unrecognized Mimicker of IgG4-RD

Zachary S. Wallace1, Yasuharu Sato2, Kazuichi Okazaki3, Judith Ferry4, Hisanori Umehara5, Aliyah Sohani6, Mitsuhiro Kawano7, Nancy Harris6, Yoshiya Tanaka8, Cory A. Perugino9, Satoshi Kubo10, James Stone4, Robert Colvin4, Tsutomu Chiba11, John H. Stone12 and Yoh Zen13, 1Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2Department of Pathology, Okayama University Graduate School of Medicine, Okayama, Japan, 3Department of Gastroenterology and Hepatology, Kansai Medical University, Osaka, Japan, 4Department of Pathology, Massachusetts General Hospital, Boston, MA, 5Kyoto University, Kyoto, Japan, 6Massachusetts General Hospital, Boston, MA, 7Division of Rheumatology, Kanazawa University Hospital, Kanazawa, Japan, 8The First Department of Internal Medicine, University of Occupational and Environmental Health, Fukuoka, Japan, 9Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, 10The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 11Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, MA, 12Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA, 13Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Castleman's disease and IgG4 Related Disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Some of clinical features of the plasma cell type of human herpesvirus-8-negative multicentric Castleman’s disease (idiopathic MCD or iMCD) are similar to those of IgG4-related disease (IgG4-RD). These conditions are associated with lymphadenopathy (LAD), a polyclonal hypergammaglobulinemia, as well as constitutional symptoms (e.g., weight loss, fatigue). The histologic features of iMCD LAD overlap with those of IgG4-related LAD. This has led to suspicion that iMCD is either overdiagnosed in some institutions or underdiagnosed in others, or that variation in disease expression across countries may alter clinical disease phenotypes. Levels of acute phase reactants, particularly the C-reactive protein (CRP), have been proposed as useful in discriminating iMCD from IgG4-RD.

Methods: American and Japanese clinicians and pathologists exchanged pathology slides of 60 cases (30 cases from the US, 30 from Japan) accompanied by clinical vignettes. Japanese investigators submitted 15 cases in which they suspected a diagnosis of iMCD and 15 cases they felt were typical IgG4-RD. Cases considered iMCD had at least focal extranodal manifestations. US investigators submitted 12 cases considered to represent IgG4-RD with an elevated CRP and 18 IgG4-RD cases with normal CRP. All investigators were blinded to CRP and IL-6 concentrations as well as treatment responses. The US investigators were blinded to the designated diagnoses of the Japanese cases. The diagnosis of iMCD was evaluated based on expert pathology opinion as well as recently published diagnostic criteria (Fajgenbaum, Blood 2017).

Results: Of the 15 suspected iMCD cases from Japan, 14 had mixed nodal and extranodal manifestations and 1 had pure extranodal abnormalities. All but one had elevated serum IgG4 concentrations. Twelve (80%) had extensive extranodal polyclonal plasma cell infiltrates with increased IgG4-positive plasma cells affecting the kidneys, lungs, and skin that were similar to the lymph node appearance. Nine (60%) fulfilled iMCD diagnostic criteria. When reviewed by expert American pathologists, however, the histopathology of all suspected iMCD cases were considered to be a nonspecific, reactive process characterized by a nonspecific plasmacytic infiltrate without regressed follicles. No association was observed between CRP elevations in the US IgG4-RD cases and whether or not the Japanese investigators considered the case to be IgG4-RD (P=0.5). None of the US IgG4-RD cases were considered iMCD by the Japanese investigators.

Conclusion: A condition characterized by multifocal LAD with polyclonal IgG4+ plasma cell infiltrates, extranodal lesions of similar histologic appearance, and elevated inflammatory markers mimics IgG4-RD and iMCD but is often not clearly classifiable as either condition even with iMCD diagnostic criteria. Although these and similar cases are commonly reported as iMCD, future studies using alternative but common nosology are critical to better characterize them. Furthermore, the diagnosis of IgG4-RD was agreed on regardless of the CRP concentration, suggesting that CRP can be elevated in otherwise typical IgG4-RD and that CRP is not a useful measure to distinguish iMCD and IgG4-RD.


Disclosure: Z. S. Wallace, None; Y. Sato, None; K. Okazaki, None; J. Ferry, None; H. Umehara, None; A. Sohani, None; M. Kawano, None; N. Harris, None; Y. Tanaka, None; C. A. Perugino, None; S. Kubo, Bristol-Myers Squibb, 8,Pfizer Inc, 8,Takeda Pharmaceutical Company Ltd, 8; J. Stone, None; R. Colvin, None; T. Chiba, None; J. H. Stone, Xencor, 2; Y. Zen, None.

To cite this abstract in AMA style:

Wallace ZS, Sato Y, Okazaki K, Ferry J, Umehara H, Sohani A, Kawano M, Harris N, Tanaka Y, Perugino CA, Kubo S, Stone J, Colvin R, Chiba T, Stone JH, Zen Y. A Multi-Organ Inflammatory Condition with Features of Idiopathic Multicentric Castleman’s Disease and IgG4-Related Disease: An Unrecognized Mimicker of IgG4-RD [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/a-multi-organ-inflammatory-condition-with-features-of-idiopathic-multicentric-castlemans-disease-and-igg4-related-disease-an-unrecognized-mimicker-of-igg4-rd/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-multi-organ-inflammatory-condition-with-features-of-idiopathic-multicentric-castlemans-disease-and-igg4-related-disease-an-unrecognized-mimicker-of-igg4-rd/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology